<code id='7DE23D6A81'></code><style id='7DE23D6A81'></style>
    • <acronym id='7DE23D6A81'></acronym>
      <center id='7DE23D6A81'><center id='7DE23D6A81'><tfoot id='7DE23D6A81'></tfoot></center><abbr id='7DE23D6A81'><dir id='7DE23D6A81'><tfoot id='7DE23D6A81'></tfoot><noframes id='7DE23D6A81'>

    • <optgroup id='7DE23D6A81'><strike id='7DE23D6A81'><sup id='7DE23D6A81'></sup></strike><code id='7DE23D6A81'></code></optgroup>
        1. <b id='7DE23D6A81'><label id='7DE23D6A81'><select id='7DE23D6A81'><dt id='7DE23D6A81'><span id='7DE23D6A81'></span></dt></select></label></b><u id='7DE23D6A81'></u>
          <i id='7DE23D6A81'><strike id='7DE23D6A81'><tt id='7DE23D6A81'><pre id='7DE23D6A81'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:8399
          Exterior photo of UnitedHealth Group building
          UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

          There’s now a two-party showdown for one of the largest home health companies in the country.

          UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

          advertisement

          The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Massive project maps cells in human brain in unprecedented detail
          Massive project maps cells in human brain in unprecedented detail

          AdobeThebrainremainsboththebody’smostimportantorgananditsleastunderstood.Butadraftatlasofthehumanbra

          read more
          STAT Plus: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial
          STAT Plus: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial

            本文由蝉大师https://www.chandashi.com/原创,如需转载,请注明出处,否则禁止转载!~~document.writeln('关注创业、电商、站长,扫描A5创业网微信二维码,定

          read more

          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm